SNSE
Sensei Biotherapeutics Inc
NASDAQ: SNSE · HEALTHCARE · BIOTECHNOLOGY
$26.62
-5.94% today
Updated 2026-04-30
Market cap
$39.04M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-16.72
Dividend yield
—
52W range
$5 – $37
Volume
0.1M
Sensei Biotherapeutics Inc (SNSE) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-74.00%
ROA
-40.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $0.00 | $-13.04M | — | — | — |
| 2019 | $0.00 | $-16.74M | — | — | — |
| 2020 | $0.00 | $-20.10M | — | — | — |
| 2021 | $0.00 | $-36.79M | — | — | — |
| 2022 | $0.00 | $-48.81M | — | — | — |
| 2023 | $0.00 | $-34.10M | — | — | — |
| 2024 | $0.00 | $-30.16M | — | — | — |
| 2025 | $0.00 | $-21.09M | — | — | — |